MedPath

Effect of Ayurvedic Medicine in Anxiety

Phase 2
Not yet recruiting
Conditions
Generalized anxiety disorder. Ayurveda Condition: OJAKSHAYAH,
Registration Number
CTRI/2025/03/082152
Lead Sponsor
Meerabai Tatyarao
Brief Summary

This study is Randomized Open labelled Controlled Clinical Trail Comparing The Safety and Efficacy Of Jivaniya Gan Dravya Vati 500 mg and Controlled Drug Jatamansi Vati 500 mg for 30 days in 74 patient With Generalised Anxiety Disorder and effect on  Generalised Anxiety Disorder 7 Scale .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
74
Inclusion Criteria

Patients up to Moderate level of Anxiety below 14 points on GAD 7 Scales,Patient having lakshnas of Ojakshaya.

Exclusion Criteria

Patient taking psychotropic drugs four weeks prior to study,Substance abuse like Alcohol,Pregnant and Lactating Mothers,Patients with Ischemic Heart Disease,Hypertension,Myocardial Infarction,Cerebrovascular event,Cardiac arrythmias,Diabetes and active Malignant disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Oral administration of 500 mg Jivaniya Gan Dravya Vati twice a day with Godugdha 5 to 10 ml for 30 days in managment of Ojakshay with special reference to Generalised Anxiety Disorder Based on diffrence in Parameters of GAD 7 scale and DSM v criteria assessed before and after treatment10 th day
Secondary Outcome Measures
NameTimeMethod
To conceptually study the Ojakshya & its management by relevant ancient methodology.To observe the adverse effect of Jivaniya Gan Dravya Vati in Ojakshaya if any.

Trial Locations

Locations (1)

Siddhakala ayurved Mahavidyalaya, sangamner

🇮🇳

Ahmadnagar, MAHARASHTRA, India

Siddhakala ayurved Mahavidyalaya, sangamner
🇮🇳Ahmadnagar, MAHARASHTRA, India
Dr Meerabai Tatyarao
Principal investigator
7020484805
lambemeera108@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.